Kazufumi Hirano

Discovery of GSK2795039, a Novel Small Molecule NADPH Oxidase 2 Inhibitor

Kazufumi Hirano, Woei Shin Chen, Adeline L.W. Chueng et al. · Antioxidants and Redox Signaling · 2015 · 197 citations · Full text

Life Sciences, Biochemistry, Pharmacology +14

Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors

Kazufumi Hirano, Ryohei Kimura, Yumi Sugimoto et al. · British Journal of Pharmacology · 2005 · 97 citations · Full text

Medicine, Neuroscience, Pharmacology +15

Cyclopropane-Based Conformational Restriction of Histamine. (1<i>S</i>,2<i>S</i>)-2-(2-Aminoethyl)-1-(1<i>H</i>-imidazol-4-yl)cyclopropane, a Highly Selective Agonist for the Histamine H₃ Receptor, Having a <i>cis</i>-Cyclopropane Structure

Yuji Kazuta, Kazufumi Hirano, Kentaro Natsume et al. · Journal of Medicinal Chemistry · 2003 · 70 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Procognitive 5-HT6 antagonists in the rat forced swimming test: Potential therapeutic utility in mood disorders associated with Alzheimer's disease

Kazufumi Hirano, Thomas M. Piers, Kirsten L. Searle et al. · Life Sciences · 2009 · 56 citations

Medicine, Neuroscience, Pharmacology +9

Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test: Analysis of serotonin and noradrenaline transporter binding

Yumi Sugimoto, Yoshinobu Kajiwara, Kazufumi Hirano et al. · European Journal of Pharmacology · 2008 · 55 citations

Medicine, Neuroscience, Pharmacology +15